IMD20 is an advanced device that uses focused ultrasound to ease pain and support tissue regeneration. By delivering precisely controlled acoustic energy to targeted areas, IMD20 activates biological responses that accelerate the body’s natural healing process without causing thermal injury or tissue ablation. The device is intended for musculoskeletal disorders, soft tissue injuries, and chronic pain, offering a non-invasive, safe, and repeatable treatment option that improves patient comfort and overall outcomes.
IMD20 operates on focused ultrasound technology. FUS delivers acoustic pressure waves to the targeted tissue, generating mechanical micro-vibrations that enhance local blood flow and oxygen delivery, thereby stimulating cellular activity. These effects contribute to reduced discomfort and improved functional performance, positioning IMD20 as a versatile platform for various clinical applications.
Stage
Clinical trial phases required for regulatory approval(Republic of Korea)
